FDA-cleared profile

Bonelogic

Disior Ltd · CT/CTA · FDA-cleared (510(k))

Authorized purpose: Bonelogic 2.2 assists orthopedic healthcare professionals with diagnosis and surgical planning by semi-automatically segmenting bony structures from CT and producing foot and ankle 3D models and measurements for clinician review.

Clinical role
Accepts CT images, assists or refines bone segmentation, builds 3D anatomy, and provides linear and angular measurement templates for planning.
Images and patients
CT/CTA · Foot/ankle
Key limitation
Keep in mind: Use is limited to CT foot and ankle anatomy and the supported segmentation workflow; user acknowledgment or correction and professional interpretation remain required, and the outputs are not a substitute for complete clinical evaluation.

Overview status: Source-reviewed overview

Report a correction
Clinical details Purpose, workflow fit, evidence, and safety record

Workflow navigation pilot

Workflow role has not yet been reviewed for this navigation pilot.

A tag identifies a documented role; it does not establish compatibility or local acceptance. Methods and sources

  • What does this software do?Authorized purpose: Bonelogic 2.2 assists orthopedic healthcare professionals with diagnosis and surgical planning by semi-automatically segmenting bony structures from CT and producing foot and ankle 3D models and measurements for clinician review.
  • Which images or clinical context are in scope?Modality: CT/CTA Anatomy or clinical context: Foot/ankle Input: Foot and ankle CT DICOM images with user identification of laterality and acknowledgment or correction of bony structures.
  • Who uses it?Intended users: Orthopedic surgeons, radiologists, and other trained healthcare professionals involved in foot and ankle diagnosis or surgical planning.
  • What does the software produce?Output: 3D foot and ankle bone models, measurements, templates, and planning views; the FDA material also describes physical replication of anatomy.
  • What is its most important limitation?Key limitation: Use is limited to CT foot and ankle anatomy and the supported segmentation workflow; user acknowledgment or correction and professional interpretation remain required, and the outputs are not a substitute for complete clinical evaluation.

Clinical takeaway. Clinical role: Bonelogic 2.2 assists orthopedic healthcare professionals with diagnosis and surgical planning by semi-automatically segmenting bony structures from CT and producing foot and ankle 3D models and measurements for clinician review.

Evidence takeaway. Evidence from the reviewed source record: K223757 FDA material reports a clinical-data verification study of 82 CT image series with 100% correct identification of foot and ankle bones and 98.8% correct identification of metal, plus separate development cohorts; these are submission-specific segmentation endpoints.

Evidence context

Evidence context not reviewed for this FDA record.

Public-label constraints

Label constraints have not been reviewed for this exact FDA record. Unknown is not all ages or evidence of unsuitability.

Public-label constraints, not patient-level eligibility or a medical recommendation. Training and evaluation populations are separate. Read the original labeling and confirm the exact release and protocol.

Purpose
Bonelogic 2.2 assists orthopedic healthcare professionals with diagnosis and surgical planning by semi-automatically segmenting bony structures from CT and producing foot and ankle 3D models and measurements for clinician review.
  • Exact FDA submission
  • Checked 2026-09-04
Workflow role
Accepts CT images, assists or refines bone segmentation, builds 3D anatomy, and provides linear and angular measurement templates for planning.
  • Exact FDA submission
  • Checked 2026-09-04
Required input
Foot and ankle CT DICOM images with user identification of laterality and acknowledgment or correction of bony structures.
  • Exact FDA submission
  • Checked 2026-09-04
Output and clinician action
3D foot and ankle bone models, measurements, templates, and planning views; the FDA material also describes physical replication of anatomy.
  • Exact FDA submission
  • Checked 2026-09-04
Care setting
Hospital and clinic orthopedic or radiology workflows.
  • Exact FDA submission
  • Checked 2026-09-04
Intended users
Orthopedic surgeons, radiologists, and other trained healthcare professionals involved in foot and ankle diagnosis or surgical planning.
  • Exact FDA submission
  • Checked 2026-09-04
Limitations
Use is limited to CT foot and ankle anatomy and the supported segmentation workflow; user acknowledgment or correction and professional interpretation remain required, and the outputs are not a substitute for complete clinical evaluation.
  • Exact FDA submission
  • Checked 2026-09-04
Evidence summary
K223757 FDA material reports a clinical-data verification study of 82 CT image series with 100% correct identification of foot and ankle bones and 98.8% correct identification of metal, plus separate development cohorts; these are submission-specific segmentation endpoints.
  • Exact FDA submission
  • Checked 2026-09-04

Evidence

Performance evidence

Metrics are shown only when they are tied to a source, endpoint, population, and tested product version. Candidate literature without exact product and version linkage is not shown as product evidence.

Evidence summary
K223757 FDA material reports a clinical-data verification study of 82 CT image series with 100% correct identification of foot and ankle bones and 98.8% correct identification of metal, plus separate development cohorts; these are submission-specific segmentation endpoints.
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Reported sensitivity
98%
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-13

Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.

Reported specificity
98.8%
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-13

Values reported in the exact-submission materials. Consult the linked source for endpoint, threshold, population, and confidence interval before comparison.

Foot and ankle bone identification

100 percent of image series

  • EndpointCorrectly identified foot and ankle bones
  • Population82 CT image series in the FDA test study
  • Tested versionBonelogic 2.2 configuration described in K223757

Metal identification

98.8 percent of image series

  • EndpointCorrectly identified metal
  • Population82 CT image series in the FDA test study
  • Tested versionBonelogic 2.2 configuration described in K223757

Metal identification sensitivity

100 percent

  • EndpointSensitivity for metal identification
  • PopulationFDA metal-identification test data
  • Tested versionBonelogic 2.2 configuration described in K223757

Metal identification specificity

98 percent

  • EndpointSpecificity for metal identification
  • PopulationFDA metal-identification test data
  • Tested versionBonelogic 2.2 configuration described in K223757

K223757 FDA evidence package for Bonelogic

  • DesignFDA 510(k) software verification and clinical-data segmentation study against orthopedic-surgeon reference labels.
  • Population82 test CT image series and development cohorts drawn from 357 studies representing 340 individual patients across U.S. and European sites.
  • Scopeexact submission
  • Tested versionBonelogic 2.2 configuration described in K223757
  • Samplen=82
  • IndependenceSponsor or vendor study

K223757

Three orthopedic surgeons provided ground truth; training, tuning, and test data were separated. Metrics are not product-wide diagnostic accuracy.

Safety and lifecycle

Postmarket record

Recall and adverse-event records are shown only after product matching. Adverse-event reports do not establish incidence or causality.

Postmarket safety review
The 2026-09-02 openFDA device-recall snapshot contained no record matched to K223757 by exact native submission identifier. This does not exclude product-family, later-version, or adverse-event information.
  • Public source
  • Exact FDA submission
  • Checked 2026-09-04

Exact-identifier review does not prove absence of all product-family safety signals.

Pricing & contracts Public price, contract terms, and reimbursement

Price not public here; enter your quote

Not publicly available: Reviewed sources do not publish an exact-product procurement price with a stated offer scope.

Reimbursement

Reimbursement
No separate named-product Medicare payment was identified in the reviewed CMS coverage material. Evaluate the product within the applicable imaging or clinical service line and verify payer, site-of-service, coding, and coverage assumptions independently.
  • Service-level, not product-specific
  • Checked 2026-09-04

No product-specific code

No separate named-product payment identified in reviewed public material

Centers for Medicare & Medicaid Services · United States

This is not a product-specific reimbursement determination. Verify payer, site-of-service, coding, and coverage assumptions independently.

IT implementation Deployment, interfaces, data handling, and support

System and version relationships

Match the AI release, system build, configuration and region. Source documentation does not establish acceptance of an installed system.

No specific system/version pairing has completed review for this FDA record. A broad DICOM or product-family statement does not establish a named viewer build's support.

Review Merge, Visage, Sectra, AGFA and IntelePACS context

Integration chain: evidence at each hop

Public source context, not tested interoperability. Each hop needs its own release/configuration evidence. Missing or unavailable routes are not documented incompatibility. All local tests are planned, not passed; no installed-system acceptance is recorded.

Acquisition/source → routing → AI processing → returned objects → viewer/worklist/report → support owner

No specific route context has been source-reviewed for this record. Obtain both endpoint builds and documents; this is not a finding of incompatibility.

  1. Acquisition/source

    Source context, not route validation: Foot and ankle CT DICOM images with user identification of laterality and acknowledgment or correction of bony structures.

    Scope: Exact FDA submission.

    Confirm scanner/model, protocol, series completeness and both software builds.

    Field checked 2026-09-04 · FDA 510(k) decision material K223757: Bonelogic

  2. Routing

    Source context, not route validation: The FDA material describes CT DICOM input, user-assisted segmentation, 3D model generation, and measurements for display or planning.

    Scope: Exact FDA submission. This is the interface boundary described in the exact FDA decision material; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.

    Name gateways, destinations, transfer rules and failure visibility; a DICOM statement does not prove a route.

    Field checked 2026-09-04 · FDA 510(k) decision material K223757: Bonelogic

  3. AI processing

    Unresolved route: Not established for the exact route.

    Scope: Exact FDA submission. The exact public FDA decision material does not establish the complete deployment topology, hosting responsibility, availability, upgrade path, or service contract.

    Confirm processing location, queue ownership, exclusions and exact AI build.

    Field checked 2026-09-04 ·

  4. Returned objects

    Source context, not route validation: 3D foot and ankle bone models, measurements, templates, and planning views; the FDA material also describes physical replication of anatomy.

    Scope: Exact FDA submission.

    Confirm object classes, units, references and whether findings, overlays or measurements reach their intended destination.

    Field checked 2026-09-04 · FDA 510(k) decision material K223757: Bonelogic

  5. Viewer/worklist/report

    Unresolved route: 3D foot and ankle bone models, measurements, templates, and planning views; the FDA material also describes physical replication of anatomy.

    Scope: Exact FDA submission.

    Confirm the named viewer/worklist/report build, display behavior and report transfer. Output support alone does not establish this endpoint. The displayed source describes output, not validated end-to-end delivery.

    Field checked 2026-09-04 · FDA 510(k) decision material K223757: Bonelogic

  6. Support owner

    Unresolved route: Not established for the exact route.

    Scope: Scope not established.

    Name the local, platform and AI supplier support owners and escalation path.

Planned local route tests

No tests below have been performed or accepted.

  1. Patient/study identity (planned). Use approved non-patient test data to verify identifiers, accession and result-to-study linkage at every hop.
  2. Study completeness (planned). Test missing views/series, partial transfer, late arrivals, priors and unsupported acquisition inputs; confirm explicit refusal or fallback.
  3. Ordering and duplicates (planned). Send out-of-order, repeated and corrected studies; verify worklist order, deduplication and no misleading stale results.
  4. Report transfer (planned). Verify output object types, annotations, units, report content, destination and availability of original images.
  5. Access (planned). Verify authorized roles, audit trail, denied access and support ownership at each destination.
  6. Latency and failures (planned). Agree a workload and turnaround target; test queues, timeouts, missing results and fallback reading.
  7. Updates and rollback (planned). Define version change control, revalidation triggers, stop-use criteria and a tested rollback route.

Local implementation checklist

Agree the evidence and acceptance owner with your team and suppliers. Checkmarks apply to this page only and are not acceptance receipts.

Open the printable evaluation checklist

Integration
The FDA material describes CT DICOM input, user-assisted segmentation, 3D model generation, and measurements for display or planning.
  • Exact FDA submission
  • Checked 2026-09-04

This is the interface boundary described in the exact FDA decision material; current local compatibility, routing, identity, archive, and downtime behavior still require acceptance testing.

Training
Only Orthopedic surgeons, radiologists, and other trained healthcare professionals involved in foot and ankle diagnosis or surgical planning should operate or interpret the product; local onboarding must cover the exact release, supported population, limitations, failure examples, escalation, downtime, and competency documentation.
  • Exact FDA submission
  • Checked 2026-09-04
Monitoring
Monitor K223757 by exact hardware, software, model, algorithm version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates. Track these product-specific limits: Use is limited to CT foot and ankle anatomy and the supported segmentation workflow; user acknowledgment or correction and professional interpretation remain required, and the outputs are not a substitute for complete clinical evaluation.
  • Exact FDA submission
  • Checked 2026-09-04

Buyer-facing monitoring guidance derived from the exact cleared scope; it is not a claim that the FDA package provides a live monitoring service.

Release and scope verification

Map installed model, build, options, population, anatomy, inputs, outputs, and enabled functions to K223757 before acceptance.

exact submission · checked 2026-09-04

Later product-family features are not evidence that this cleared release includes them.

Deployment boundary

The exact public deployment topology remains incomplete; establish hosting responsibility, data flow, availability, upgrade, service, and downtime boundaries locally.

exact submission · checked 2026-09-04

FDA-described deployment boundaries do not establish current hosting contracts, security controls, uptime, or local qualification.

Interoperability acceptance

The FDA material describes CT DICOM input, user-assisted segmentation, 3D model generation, and measurements for display or planning.

exact submission · checked 2026-09-04

Test representative identifiers, orientation, geometry, measurements, units, routing, failure handling, and round trips locally.

Clinical acceptance

Use a signed local test set for the supported population and workflow. Include common and difficult cases, exclusions, acquisition variation, failed or low-quality inputs, reviewer overrides, and downstream effects. Use is limited to CT foot and ankle anatomy and the supported segmentation workflow; user acknowledgment or correction and professional interpretation remain required, and the outputs are not a substitute for complete clinical evaluation.

exact submission · checked 2026-09-04

Define stop-use, escalation, rollback, and revalidation triggers before production use.

Economic evaluation

Model capital and recurring cost against net staff time after review, throughput, repeat imaging or rework, room time, consumables, infrastructure, training, service, downtime, upgrade, and replacement costs.

product family · checked 2026-09-04

No exact-product price was found in the reviewed public material; productivity or value claims require local evidence.

Lifecycle monitoring

Monitor K223757 by exact hardware, software, model, algorithm version, patient population, anatomy, protocol, operator, input quality, output edits or overrides, failed studies, repeat acquisition or rework, downstream impact, downtime, incidents, recalls, and updates.

exact submission · checked 2026-09-04

Revalidate after material software, hardware, model, protocol, interface, or clinical-policy changes.

Sources & review details FDA identity, research record, source ledger, and history

Regulatory identity

FDA record and catalog context

The FDA listing establishes the regulatory identity. It does not by itself establish local workflow fit, pricing, security, or performance in your environment.

FDA submission
K223757
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Modality
CT/CTA
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Anatomy
Foot/ankle
  • FDA source
  • Exact FDA submission
  • Checked 2026-09-04
Clearance type
510(k)
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
Decision date
2023-12-08
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31
FDA status
FDA-cleared
  • FDA source
  • Exact FDA submission
  • Checked 2026-08-31

Research record

What has been checked

This audit distinguishes completed source review from fields that have not yet been researched.

Human reviewedStatus
2026-09-04Last searched
32Fields reviewed
11Source classes checked
17Screened PubMed leads
1Screened trial leads
0Unreviewed FDA recall leads

Screened 17 PubMed and one ClinicalTrials.gov record. Bonelogic mentions are versions 1.0, 2.0, 2.1, CMF, developer-level, or unstated rather than the K223757 Bonelogic 2.2 configuration; all 18 were quarantined and none was promoted. The current discovery snapshot contains 17 PubMed and 1 ClinicalTrials.gov candidate records; its dated, count-matched human screening remains current. Unlinked candidates remain quarantined. Native FDA recall identifiers produced 0 postmarket candidate records; 0 have been reviewed (0 published, 0 rejected) and 0 remain unreviewed.

Candidate leads were screened against the exact product and tested version. Unlinked records remain quarantined.

Source classes: fda ai list, fda decision summary, acr ai central product, fda decision material, peer reviewed literature, clinical trial registry, reimbursement policy, fda device recall, pubmed, clinical trials, openfda device recall

Field review details

Recorded state, verification date, notes and sources for fields without a publishable value. Conflicting records stay explicitly unsettled here; no plain settled value is shown for them.

  • Public pricing: Not publicly available - checked 2026-09-04 - Exact FDA submission

    No public list price for the exact cleared configuration was found. Obtain a written quote separating hardware or license basis, implementation, interfaces, infrastructure, training, service, upgrades, renewal, consumables, and exit costs.

  • Pricing model: Not yet reviewed
  • Setup and integration fees: Not yet reviewed
  • Recurring fees: Not yet reviewed
  • Minimum commitment: Not yet reviewed
  • Contract duration: Not yet reviewed
  • Renewal terms: Not yet reviewed
  • Cancellation terms: Not yet reviewed
  • Support and service terms: Not yet reviewed
  • Trial or pilot terms: Not yet reviewed
  • Deployment: Not publicly available - checked 2026-09-04 - Exact FDA submission

    The exact public FDA decision material does not establish the complete deployment topology, hosting responsibility, availability, upgrade path, or service contract.

  • Data hosting location: Not yet reviewed
  • Data retention: Not yet reviewed
  • Documented data use: Not yet reviewed
  • Hardware requirements: Not yet reviewed
  • Network requirements: Not yet reviewed
  • Identity and access: Not yet reviewed
  • Security: Not publicly available - checked 2026-09-04 - Exact FDA submission

    Public materials reviewed for this exact release do not establish the complete security posture. Request data-flow, identity, audit, encryption, retention, remote-access, vulnerability-management, backup, and incident-response evidence.

  • Installation timeline: Not yet reviewed

7 sources - 3 history items

Source ledger

  1. FDA 510(k) decision material K223757: Bonelogic

    U.S. Food and Drug Administration - Published 2023-12-08 - Accessed 2026-09-04

    Scope: identity, productIdentity, purpose, clinicalUse, modality, anatomy, intendedUsers, careSetting, workflowRole, input, output, limitations, evidenceSummary

  2. Artificial Intelligence-Enabled Medical Devices

    U.S. Food and Drug Administration - Accessed 2026-08-31

    Scope: regulatoryIdentity, modalityContext

  3. Bonelogic model card (K223757)

    American College of Radiology - Published 2026-08-17 - Accessed 2026-09-01

    Scope: intendedUsers, output, evidenceSummary, integration, anatomy, evidenceStudies, implementationCapabilities

  4. PubMed biomedical literature index

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery

  5. ClinicalTrials.gov study registry

    U.S. National Library of Medicine - Accessed 2026-09-01

    Scope: evidenceDiscovery, studyStatus

  6. Medicare Coverage Database

    Centers for Medicare & Medicaid Services - Accessed 2026-09-01

    Scope: coverage, codingContext

  7. openFDA Device Recall API

    U.S. Food and Drug Administration - Accessed 2026-09-02

    Scope: recallDiscovery, nativeSubmissionMatching

Research history

  1. K223757 FDA decision

    Regulatory record

    510(k)

  2. Source-review record updated

    Research record

    human reviewed

  3. Reader overview source-reviewed

    Editorial review

    Source-reviewed editorial overlay

Alternatives

Related tools to compare

FDA-cleared K221432

Customize

3D-Side SA

Customize supports adult total ankle arthroplasty planning with CT segmentation, 3D models, implant positioning and sizing, plan review, and X-ray-informed planning.

Modality
CT/CTA
Anatomy
Foot/Ankle
Decision
2022-08-03
FDA-cleared K240642

SMART Bun-Yo-Matic CT

Disior Ltd

Authorized purpose: Foot and ankle CT analysis for three-dimensional visualization, measurements, and preoperative surgical planning by qualified orthopaedic professionals.

Modality
CT/CTA
Anatomy
Foot/Ankle
Decision
2024-06-20
FDA-cleared K260322

Acorn 3D Software (AC-SEG-4009); Acorn 3DP Model (AC-101-XX)

Mighty Oak Medical

Authorized purpose: Acorn 3D Software and Acorn 3DP Model process CT, synthetic CT, and CT angiography for segmentation, visualization, measurement, treatment planning, and three-dimensional printing, including adult and pediatric spine trajectory planning.

Modality
CT/CTA
Anatomy
Spine; craniomaxillofacial; musculoskeletal anatomy; and patient-specific printed models
Decision
2026-06-11

Correct this exact record

Copy this public context and add the field, proposed wording and original source before sending. Nothing here is submitted automatically. Form-specific prefill has not been verified.

Open existing correction destination

Permission to display a submission is not evidence verification. A submission enters editorial review; it does not approve a public change. Form availability, data entry, receipt, review and publication are separate steps. Data entry and receipt remain unverified.

Accepted repository change history

No entry has been added to this scoped change history for this record. This is not proof that the record never changed.

Correction policy and limits · Public repository change history